A detailed history of Price T Rowe Associates Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,545,961 shares of PRME stock, worth $4.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,545,961
Previous 1,545,961 -0.0%
Holding current value
$4.48 Million
Previous $7.95 Million 24.7%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.3 - $8.03 $4.2 Million - $7.84 Million
-976,629 Reduced 38.72%
1,545,961 $7.95 Million
Q1 2024

May 15, 2024

BUY
$6.35 - $9.39 $1.91 Million - $2.83 Million
301,431 Added 13.57%
2,522,590 $17.7 Million
Q4 2023

Feb 14, 2024

BUY
$5.59 - $9.55 $267,134 - $456,375
47,788 Added 2.2%
2,221,159 $19.7 Million
Q3 2023

Nov 14, 2023

SELL
$9.5 - $15.07 $1.52 Million - $2.42 Million
-160,460 Reduced 6.88%
2,173,371 $20.7 Million
Q2 2023

Aug 14, 2023

BUY
$11.41 - $17.05 $16.3 Million - $24.4 Million
1,430,090 Added 158.24%
2,333,831 $34.2 Million
Q1 2023

May 15, 2023

SELL
$11.21 - $21.11 $16.5 Million - $31.1 Million
-1,474,841 Reduced 62.01%
903,741 $11.1 Million
Q4 2022

Feb 14, 2023

BUY
$15.2 - $21.12 $36.2 Million - $50.2 Million
2,378,582 New
2,378,582 $44.2 Million

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $278M
More about PRME
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.